The regulatory, evaluation, pricing and reimbursement pathway for medicines in the UK: combining innovation and access
- DOI
- 10.30968/rbfhss.2022.132.0804
- Published
- June
- Container
- Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.30968/rbfhss.2022.132.0804,
title = {The regulatory, evaluation, pricing and reimbursement pathway for medicines in the UK: combining innovation and access},
author = {Adriana M. IVAMA-BRUMMELL and Pilar PINILLA-DOMINGUEZ and Aline N. BIZ},
year = {2022},
journal = {Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde},
doi = {10.30968/rbfhss.2022.132.0804},
url = {https://doi.org/10.30968/rbfhss.2022.132.0804}
}RIS
TY - JOUR TI - The regulatory, evaluation, pricing and reimbursement pathway for medicines in the UK: combining innovation and access AU - Adriana M. IVAMA-BRUMMELL AU - Pilar PINILLA-DOMINGUEZ AU - Aline N. BIZ PY - 2022 JO - Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde DO - 10.30968/rbfhss.2022.132.0804 UR - https://doi.org/10.30968/rbfhss.2022.132.0804 ER -
APA
IVAMA-BRUMMELL, A. M., PINILLA-DOMINGUEZ, P., & BIZ, A. N. (2022). The regulatory, evaluation, pricing and reimbursement pathway for medicines in the UK: combining innovation and access. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde. https://doi.org/10.30968/rbfhss.2022.132.0804
Source records
- doaj · retrieved 2026-09-26T06:21:48.808Z